American Bio Medica Corporation announced that it has entered into securities purchase agreement with a non-affiliated, accredited investor for a private placement of 2,500,000 shares at a price of $0.04 per share for gross proceeds of $100,000 on October 18, 2021. The shares issued will be subject to hold period.